Panel Discussion and Audience Q&A
6:53
Myeloproliferative Neoplasm
Panel Discussion and Audience Q&A
Myeloproliferative Neoplasm Similar Videos
Similar Videos
-
Naveen Pemmaraju, MD; The University of Texas MD Anderson Cancer Center; 5Live #ASH21
7:42
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Therapeutic Options for Patients with JAK-Inhibitor–Naïve Myelofibrosis_Naveen Pemmaraju, MD
21:38
-
Treatment Selection and Emerging Therapeutic Options in JAK-Inhibitor Refractory/ Intolerant Myelofibrosis_Srdan Verstovsek, MD, PhD
16:54
